By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Dictionary
    • Browse A–Z
    • About the Project
    • Contribute a Term
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Dictionary
    • Browse A–Z
    • About the Project
    • Contribute a Term
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > What England’s Lyme Disease Surge Means for Clinical Practice and Patient Care

What England’s Lyme Disease Surge Means for Clinical Practice and Patient Care

GMJ
Last updated: 22/07/2026 13:07
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
Chart showing rising Lyme disease case numbers in England with tick illustration
Laboratory-confirmed Lyme disease cases in England jumped 22% to 1,168 in 2025, driven by expanding tick populations and environmental changes. The UK Health Security Agency reports the disease remains the country's most common locally acquired vector-borne infection. — Photo by Erik Karits on Pexels (Pexels License)
SHARE
1 min read|144 words

England’s 22% increase in Lyme disease cases to 1,168 in 2025 carries important clinical implications for healthcare providers. The expansion of tick populations and year-round transmission risk demands heightened diagnostic vigilance, particularly as tick exposure is no longer confined to traditional seasonal windows. Physicians should maintain a lower threshold for suspecting Lyme disease, especially in patients presenting with characteristic erythema migrans rash or systemic symptoms following potential tick exposure.

Early antibiotic treatment initiated within weeks of symptom onset offers the best clinical outcomes and can prevent serious complications including neurological and cardiac manifestations. Public health guidance emphasizes comprehensive tick prevention strategies, including appropriate clothing, insect repellents, and post-exposure tick removal. Healthcare systems should ensure adequate access to timely diagnostic testing and treatment protocols, while patient education programs should reinforce awareness of expanding transmission risks in evolving tick habitats across England.

Read the full article on GMJ Newsroom.

Was this article helpful?

GMJ Brief · Takeaway

📰 Read the full article: Lyme disease cases surge 22% in England as tick populations expand →

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Ethiopia Study Reveals Stakeholder Concerns Over Novel Malaria Treatments

A qualitative study in Ethiopia reveals that health workers and patients view…

Sitafloxacin monotherapy matches doxycycline-rifampicin for brucellosis treatment in landmark trial

A multicenter randomized trial in The Lancet Regional Health – Western Pacific…

Ultra-processed foods linked to higher kidney cancer risk in large US study

A prospective analysis of over 300,000 US adults found that higher consumption…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

EBOLA CROSS-BORDER TRANSMISSION: DRC-UGANDA – PHEIC DECLARATION

By
Prof. Giorgi Pkhakadze
31/05/2026
Medical illustration showing lymphatic system and urinary tract connection

Chyluria Prevalence: Understanding a 1-in-1-Million Rarity

By
Prof. Giorgi Pkhakadze
22/07/2026
Diagram showing the 20 amino acids classified by chemical structure: aliphatic, aromatic, acidic, basic, hydroxyl-containing, sulphur-containing, and amidic groups.

Announcement: The 20 amino acids: life’s molecular alphabet explained

By
Prof. Giorgi Pkhakadze
07/08/2026
Diagram showing creatine kinase shuttle system between mitochondria and myofibril, with phosphocreatine transferring phosphate to regenerate ATP

Beyond the Myths: How Creatine Actually Powers Muscle Performance

By
Prof. Giorgi Pkhakadze
26/07/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?